Last Update 20 Feb 26
CRISIL: Dividend Decisions And Steady Assumptions Will Support A Positive Outlook
Analysts have kept the CRISIL price target unchanged at ₹5,106.50, reflecting updated assumptions that combine slightly higher revenue growth expectations with a marginally lower profit margin and a modestly adjusted future P/E multiple.
What's in the News
- Board meeting scheduled on February 13, 2026 to consider and approve audited consolidated and standalone financial results for the fourth quarter and year ended December 31, 2025, and to consider the payment of a final dividend for the 2025 financial year (company filing).
- Board meeting scheduled on February 12, 2026 to consider the payment of a final dividend for the financial year ending December 31, 2025 and any other matters (company filing).
- Recommendation of a final dividend of ₹28 per equity share of face value ₹1 for the financial year ended December 31, 2025, subject to shareholder approval at the AGM on April 17, 2026; the record date is April 3, 2026 and the proposed payment date is April 23, 2026 (company filing).
Valuation Changes
- Fair Value: The model fair value remains unchanged at ₹5,106.50.
- Discount Rate: The discount rate has risen slightly from 13.81% to 13.84%.
- Revenue Growth: The revenue growth assumption has increased slightly from 12.85% to 13.05%.
- Net Profit Margin: The net profit margin assumption has eased slightly from 24.03% to 23.56%.
- Future P/E: The future P/E multiple assumption has softened from 45.72x to 44.29x.
Key Takeaways
- Revenue and margin growth face risks from temporary factors, market normalization, automation-driven commoditization, and mounting regulatory compliance costs.
- New competition in analytics, advisory, and ESG ratings could undermine market share and limit long-term earnings expansion.
- Expanding demand, premium market positioning, and strategic innovation initiatives position CRISIL for sustained growth, stronger profitability, and increased global diversification.
Catalysts
About CRISIL- An analytical company, provides ratings, research, and risk and policy consulting services in India, Europe, North America, and internationally.
- The stock appears to be pricing in ongoing, unusually high growth in Ratings revenues that may be at risk of mean-reverting, as recent outperformance was driven partly by temporary factors (large deals, investor preference shifts) rather than a structural expansion in the overall market; if underlying bond and bank loan issuance normalize or slow, top-line (revenue) growth could decelerate.
- Investors may be expecting the rapid digital adoption and use of GenAI and analytics to lead to sustained or higher margins, but increasing automation and the spread of advanced analytics tools could actually commoditize ratings and analytics offerings, pressuring fee rates and net margins over the medium term.
- Market appears to be discounting elevated future global demand for Crisil's analytics and advisory offerings, yet global macro uncertainty, continued discretionary spending cuts by clients, and increased competition from in-house bank teams or fintechs could dampen growth in the Research, Analytics, and Solutions segment, impacting both revenues and earnings.
- Increased regulatory scrutiny and anticipated requirements for heightened compliance (both in India and globally) may bring higher compliance and operational costs to the rating agency model, potentially offsetting margin expansions from technology investments and impacting future net margins.
- The move toward ESG ratings and disclosures, while an opportunity, also carries the risk of new specialized entrants or alternative assessment frameworks reducing the market share of legacy providers like Crisil; this could moderate the company's longer-term revenue growth expectations if current leadership is eroded.
CRISIL Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming CRISIL's revenue will grow by 10.9% annually over the next 3 years.
- Analysts assume that profit margins will increase from 21.5% today to 23.6% in 3 years time.
- Analysts expect earnings to reach ₹10.9 billion (and earnings per share of ₹140.3) by about August 2028, up from ₹7.3 billion today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 47.4x on those 2028 earnings, down from 52.3x today. This future PE is greater than the current PE for the IN Capital Markets industry at 24.0x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 14.78%, as per the Simply Wall St company report.
CRISIL Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- The deepening financialization of the Indian economy and healthy medium-term growth prospects (including investments, efficiency, and deregulation) are expected to drive robust demand for CRISIL's core services, suggesting potential for consistent revenue expansion if economic tailwinds materialize.
- CRISIL's entrenched relationships and client preference for its best-in-class ratings, coupled with strong market share gains, indicate increasing pricing power and stickiness, which could enable it to outperform competitors and sustain higher net margins.
- Integration with S&P Global and expansion into new growth areas (such as analytics, GenAI-enabled solutions, and global benchmarking) provide avenues for international diversification, operational leverage, and new revenue streams-boosting long-term earnings potential.
- Regulatory trends and increasing requirements for transparency, analytics, and compliance are likely to structurally increase the relevance of CRISIL's offerings, making its services more integral to financial market participants and supporting secular growth in topline and earnings.
- Ongoing investments in technology, proprietary digital platforms, and operational excellence initiatives suggest potential for margin improvement and structural cost efficiency, supporting higher profitability even in periods of market volatility.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of ₹4670.0 for CRISIL based on their expectations of its future earnings growth, profit margins and other risk factors.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be ₹46.1 billion, earnings will come to ₹10.9 billion, and it would be trading on a PE ratio of 47.4x, assuming you use a discount rate of 14.8%.
- Given the current share price of ₹5206.5, the analyst price target of ₹4670.0 is 11.5% lower. Despite analysts expecting the underlying buisness to improve, they seem to believe the market's expectations are too high.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on CRISIL?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

